General Methods. Syntheses of oligonucleotide precursors (17 and 21) to 8, 9, and 11 and general synthetic procedure for preparing 3'-32 P-t-8, 5'-32 P-t-8, 5'-32 P-b-8, and 3'-32 P-b-8 was previously reported. 1 Oligonucleotides containing native nucleotides were deprotected using 1:1 mixture of aqueous methylamine (40%)-concentrated NH 4 OH at 55 °C for 1 h. Oligonucleotides were purified by 20% denaturing polyacrylamide gel electrophoresis (PAGE), isolated by the crush and soak method, and desalted using C-18-Sep-Pak cartridges (Waters). Oligonucleotides were 5'-32 P-labeled by T4 polynucleotide kinase (New England Biolabs) and γ-32 P-ATP (Perkin-Elmer) using standard protocols. Radiolabeling of the 3'-termini was done using α-32 Pcordycepin triphosphate (Perkin-Elmer) and terminal deoxynucleotidyl transferase (NEB).
Radioisotopic "fill in" experiments at 3'-termini were carried out with klenow (exo-) (NEB) and α-32 P-dCTP (Perkin-Elmer). CviQI, Fnu4HI, BsrBI, Taq α I, HpyCH4V, NEB 2.0, NEB 3.1, and CutSmart buffer were from NEB.
Preparation of 5'-32 P-t-11. The preparation of 5'-32 P-t-11 is described below in Scheme S1.
Oligonucleotide 19 ( Figure S1 ) (80 pmol) was 5'-32 P-labeled in a reaction (80 µL) containing 1 × T4 PNK buffer (70 mM TRIS-HCl pH 7.6, 10 mM MgCl 2 , 5 mM DTT), 50 µCi γ-32 P-ATP, and 30 U of T4 PNK at 37 °C for 2 h. Excess γ-32 P-ATP was removed by passing the reaction through a 1 mL Sephadex G25 column. The specific activity was determined by counting the radioactivity (using a liquid scintillation counter) and measuring the concentration of 19 (A 260 ).
Separately, 17 (40 pmol) was 5'-phosphorylated on the template strand in a 25 µL reaction containing 1 × T4 PNK buffer, ATP (80 pmol), and 30 U of T4 PNK at 37 °C for 1 h. Both phosphorylation reactions were stopped by heating at 65 °C for 30 min. The phosphorylated products were hybridized with 160 pmol each of 18 and 20 in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium chloride solution by slowly cooling from 90 °C to 16 °C. The reaction was S3 incubated overnight at 16 °C in presence of T4 DNA ligase (50 U) and 1 × ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 10 mM DTT, 1 mM ATP). Formamide loading buffer (50 µL, 90% formamide, 10 mM EDTA, pH 8.0) was added, followed by heating at 90 °C for 5 min and cooling on ice prior to purification by 20% denaturing PAGE (37 × 32 × 0.04 cm). The gel was run under limiting power (55 W) for 18 h. The product band was excised from the gel, crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 mM EDTA).
The supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge to provide 5'-32 P-t-11. The yield (10-20%) of 5'-32 P-t-11 was determined based on the specific activity of 5'-32 P-19.
Preparation of 11 radiolabeled internally on 3'-side of abasic site analog (W).
The preparation of internally radiolabeled 11 is described below in Scheme S2. Oligonucleotide 18 (80 pmol) was 5'-32 P-labeled in reaction (80 µL) containing 1 × T4 PNK exchange buffer buffer (50 mM imidazole-HCl pH 6.4, 18 mM MgCl 2 , 5 mM DTT, 0.1 mM spermidine, and 0.1 mM ADP), 6% PEG 8000 solution (w/v), 12 µM ATP, 50 µCi γ-32 P-ATP, and 30 U of T4 PNK at 37 °C for 2 h. Excess γ-32 P-ATP was removed by passing the reaction through a 1 mL Sephadex G25 column. The specific activity was determined by counting the radioactivity (using Scheme S1:
a liquid scintillation counter) and measuring the concentration of 18 (A 260 ). Separately, 17 (40 pmol) was 5'-phosphorylated on the template strand in a 25 µL reaction containing 1 × T4 PNK buffer, ATP (80 pmol), and 30 U of T4 PNK at 37 °C for 1 h. Both phosphorylation reactions were stopped by heating at 65 °C for 30 min. The phosphorylated products were hybridized with 160 pmol each of 19 and 20 in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium chloride solution by slowly cooling from 90 °C to 16 °C. The reaction was incubated overnight at 16 °C in presence of T4 DNA ligase (50 U) and 1 × ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 10 mM DTT, 1 mM ATP). Formamide loading buffer (50 µL, 90% formamide, 10 mM EDTA, pH 8.0) was added, followed by heating at 90 °C for 5 min and cooling on ice prior to purification by 20% denaturing PAGE (37 × 32 × 0.04 cm). The gel was run under limiting power (55 W) for 18 h. The product band was excised from the gel, crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge to provide internally radiolabeled 11. The yield (10-20%) of 5'-32 P-t-11 was determined based on the specific activity of 5'-32 P-18.
Scheme S2:
Preparation of 3'-32 P-t-9. The preparation of 3'-32 P-t-9 is described below in Scheme S3.
Oligonucleotide 22 (80 pmol) was 3'-32 P-labeled in reaction (80 µL) containing 1 × TdT buffer buffer (50 mM KOAc, 20 mM Tris-OAc, 10 mM MgCl 2 , pH 7.9), 40 µCi α-32 P-cordycepin triphosphate, and 30 U of terminal deoxynucleotidyl transferase at 37 °C for 2 h. The reaction was stopped by heating at 75 °C for 30 min. Excess α-32 P-cordycepin triphosphate was removed by passing the reaction through a 1 mL Sephadex G25 column. The specific activity was determined by counting the radioactivity (using a liquid scintillation counter) and measuring the concentration of 22 (A 260 ). The radiolabeled 22 was hybridized with 21 (50 pmole) in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium chloride solution (100 µL) by slowly cooling from 90 °C to 16 °C. The reaction was incubated overnight at 16 °C in presence of T4 DNA ligase (50 U) and 1 × ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 10 mM DTT, 1 mM ATP). Formamide loading buffer (50 µL, 90% formamide, 10 mM EDTA, pH 8.0) was added, followed by heating at 90 °C for 5 min and cooling on ice prior to purification by 20% denaturing PAGE (37 × 32 × 0.04 cm). The gel was run under limiting power (55 W) for 18 h.
The product band was excised from the gel, crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge, concentrated and then thermally annealed with 10 to provide 3'-32 P-t-9.
The yield (10-20%) of 3'-32 P-t-9 was determined based on the specific activity of 3'-32 P-22.
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Preparation of 3'-32 P-b-9. The preparation of 3'-32 P-b-9 is described below in Scheme S4.
Oligonucleotide 22 (160 pmol) was hybridized with 21 (50 pmol) in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium chloride solution (20 µL) by slowly cooling from 90 °C to 16 °C.
The reaction was incubated overnight at 16 °C in presence of T4 DNA ligase (50 U) and 1 × ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 10 mM DTT, 1 mM ATP). The ligation was stopped by heating at 65 °C for 30 min. After addition of 23 (160 pmol) to the solution, it was hybridized with the cross-link by slowly cooling down from 90 °C to 16 °C. The crosslinked substrate was then 3'-32 P-labeled in its bottom strand using a "fill in" reaction (150 µL) containing 1 × NEB 2.0 buffer (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, 1 mM dTT, pH 7.9), 30 µCi α-32 P-dCTP, and 30 U of klenow exo(-) at 37 °C for 3 h. The "fill in" reaction was stopped by heating at 75 °C for 30 min. Excess α-32 P-dCTP was removed by passing the reaction through a 1 mL Sephadex G25 column. The specific activity was determined by counting the radioactivity (using a liquid scintillation counter) and assuming hundred percent recovery of the radiolabeled cross-linked substrate. Formamide loading buffer (50 µL, 90% formamide, 10 mM EDTA, pH 8.0) was added to the recovered substrate, followed by heating at 90 °C for 5 min and cooling on ice prior to purification by 20% denaturing PAGE (37 × 32 × 0.04 cm). The gel was Scheme S3:
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run under limiting power (55 W) for 18 h. The product band was excised from the gel, crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 mM EDTA).
The supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge, concentrated and then thermally annealed with 10 to provide 3´-32 P-b-9. The yield (10-20%) of 3´-32 P-b-9 was determined based on the specific activity of 3´-32 P-radiolabeled cross-link.
Preparation of 5´-32 P-b-9. The preparation of 5´-32 P-b-9 is described in Scheme S5.
Oligonucleotide 21 (50 pmol) was 5´-32 P-labeled in reaction (80 µL) containing 1 × T4 PNK buffer (70 mM Tris-HCl pH 7.6, 10 mM MgCl 2 , 5 mM DTT), 50 µCi γ-32 P-ATP, and 30 U of T4 PNK at 37 °C for 2 h. The phosphorylation reaction was stopped by heating at 65 °C for 30 min.
Excess γ-32 P-ATP was removed by passing the reaction through a 1 mL Sephadex G25 column.
The specific activity was determined by counting the radioactivity (using a liquid scintillation counter) and measuring the concentration of 21 (A 260 ). The 32 P-radiolabeled 21 were hybridized with 22 (160 pmol) in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium chloride solution by slowly cooling from 90 °C to 16 °C. The reaction was incubated overnight at 16 °C in S8 presence of T4 DNA ligase (50 U) and 1 × ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 10 mM DTT, 1 mM ATP). Formamide loading buffer (50 µL, 90% formamide, 10 mM EDTA, pH 8.0) was added, followed by heating at 90 °C for 5 min and cooling on ice prior to purification by 20% denaturing PAGE (37 × 32 × 0.04 cm). The gel was run under limiting power (55 W) for 18 h. The product band was excised from the gel, crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge, concentrated and then thermally annealed with 10 to provide 5´-32 P-b-9. The yield (10-20%) of 5´-32 P-b-9 was determined based on the specific activity of 5´-32 P-21.
Preparation of 5´-32 P-t-9. The preparation of 5´-32 P-t-9 is described below in Scheme S6.
Oligonucleotide 22 (1.5 nmole) was hybridized with 21 (3 nmole) in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium chloride solution (50 µL) by slowly cooling from 90 °C to 16 °C.
The reaction was incubated overnight at 16 °C in presence of T4 DNA ligase (50 U) and 1 × ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 10 mM DTT, 1 mM ATP). Formamide loading buffer (50 µL, 90% formamide, 10 mM EDTA, pH 8.0) was added, followed by heating Scheme S5: at 90 °C for 5 min and cooling on ice prior to purification by 20% denaturing PAGE (37 × 32 × 0.1 cm). The gel was run under limiting power (45 W) for 14 h. The product band was detected using UV, excised from the gel, crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The supernatant was concentrated by repeatedly mixing with 1-butane and then desalted by precipitation. The yield of ligation (22%) was determined from the concentration of isolated product (A 260 ). In a separate reaction 10 (20 pmol) was 5´-32 Plabeled in reaction (80 µL) containing 1 × T4 PNK buffer (70 mM Tris-HCl pH 7.6, 10 mM MgCl 2 , 5 mM DTT), 50 µCi γ-32 P-ATP, and 30 U of T4 PNK at 37 °C for 2 h. The 5´-32 P-10 was then hybridized with the ligated cross-link to obtain 5´-32 P-t-9.
Restriction Enzyme Treatment for Characterization of 5´-32 P-t-11. Taq α I (10 U) and 5´-32 P-t-11 were incubated in an 8 µL reaction containing of 1 × CutSmart buffer (50 mM potassium acetate, 20 mM Tris•acetate, 10 mM magnesium acetate, 100 µg/mL BSA, pH 7.9) at 65°C (Taq α I) for 1 h. In two independent experiments, CviQI was incubated with 5´-32 P-t-8 or 5´-32 P-t-11 in 8 µL reactions containing of 1 × NEB 3.1 buffer (100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl 2 , 100 µg/mL BSA, pH 7.9) at room temperature for 1 h. After 1 h, formamide loading Scheme S6: S10 buffer (2 µL, 90% formamide, 10 mM EDTA, pH 8.0) was added to these reactions, followed by heating at 90°C (2 min), and cooling on ice. The reactions were analyzed by 15% denaturing PAGE.
Restriction Enzyme Treatment for Characterization of Internally Radiolabeled 11. The appropriate restriction enzyme (Fnu4HI and HpyCH4V) (10 U) and internally radiolabeled 11 were incubated in an 8 µL reaction containing of 1 × CutSmart buffer (50 mM potassium acetate, 20 mM Tris•acetate, 10 mM magnesium acetate, 100 µg/mL BSA, pH 7.9) at 37°C for 1 h, at which time formamide loading buffer (2 µL, 90% formamide, 10 mM EDTA, pH 8.0) was added, followed by heating at 90°C (2 min), and cooling on ice. The reactions were analyzed by 15% denaturing PAGE.
Restriction Enzyme Treatment of 3'-32 P-b-9, 3'-32 P-t-9, 5'-32 P-b-9, and 5'-32 P-t-9. The restriction enzyme BsrBI (10 U) and 9 were incubated in a 8 µL reaction containing of 1 × CutSmart buffer (50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 100 µg/mL BSA, pH 7.9) at 37°C for 1 h. In a separate reaction, CviQI and 9 were incubated in a 8 µL reaction containing of 1 × NEB 3.1 buffer (100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl 2 , 100 µg/mL BSA, pH 7.9) at room temperature for 1 h. The reactions were added with formamide loading buffer (2 µL, 90% formamide, 10 mM EDTA, pH 8.0) followed by heating at 90°C (2 min) and cooling on ice. The reactions were analyzed by 12% denaturing PAGE.
Determination of thermal stability of 5'-32 P-t-9 under nucleotide excision repair conditions.
Oligonucleotide 5'-32 P-t-9 (2 nM) was incubated with 10 (10 nM) for 1 h in 60 µL reaction containing 1 × NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 50 mM KCl, 5 mM dTT, and ATP 1 mM) at 55 °C for 3 h . Aliquots (9 µL) were taken at 0, 5, 10, 15, 30 and 60 min and S11 mixed with glycerol loading buffer (2 µL, 80% glycerol in water, v/v). The exchange was analyzed by 20% non-denaturing PAGE.
Determination of thermal stability of 13 under nucleotide excision repair conditions.
Oligonucleotide 5'-32 P-13 (0.26 nM) was incubated with 15 (0.26 nM or 2.6 nM) in a 50 µL reaction containing 1 × NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 50 mM KCl, 5 mM dTT, and ATP 1 mM) at 55 °C for 3 h. The experiment was cooled to 4 °C and mixed with glycerol loading buffer (5.5 µL, 80% glycerol in water, v/v). The exchange was analyzed by 15% non-denaturing PAGE. S12 Figure S1 . Cross-link precursors and oligonucleotides used to make 8, 9, and 11. Figure S2 . Restriction enzyme sites present on 8, 9 and 11. Figure S3 . Restriction enzyme treatment on 5'-32 P-t-11 and 5'-32 P-t-8. (A.) Denaturing PAGE gel (15%) analysis of restriction enzyme treatment of 5'-32 P-t-11. Lane 1, 10 base pair DNA ladder. Lane 2, 5'-32 P-t-11 without any treatment. Lane 3, 5'-32 P-t-11 treated with with Taq α I. (B.) Denaturing PAGE gel (15%) analysis of restriction enzyme treatment of 5'-32 P-t-11 and 5'-32 P-t-8. Lane 1, 5'-32 P-t-8 without any treatment. Lane 2, 5'-32 P-t-8 treated with CviQI. Lane 3, 5'-32 Pt-11 without any treatment. Lane 2, 5'-32 P-t-11 treated with CviQI. Figure S4 . Representative 12% denaturing PAGE gel analysis of restriction enzyme treatment on 11 internally labeled at 3'-side of the abasic site analog (W). Lane 1, 10 base pair DNA ladder. Lane 2, internally labeled 11 without any treatment. Lane 3, internally labeled 11 treated with Fnu4HI. Lane 3, internally labeled 11 treated with HpyCH4V. Figure S5 . Restriction enzyme treatment on 3'-32 P-b-9, 3'-32 P-t-9, 5'-32 P-b-9, and 5'-32 P-t-9. (A.) Representative 15% denaturing PAGE gel analysis of restriction enzyme treatment of 3'-32 P-b-9. Lane 1, 10 base pair DNA ladder. Lane 2, 3'-32 P-b-9 without any treatment. Lane 3, 3'-32 P-b-9 treated with CviQI. Lane 4, 3'-32 P-b-9 treated with BsrBI. (B.) Representative 15% denaturing PAGE gel analysis of restriction enzyme treatment of 3'-32 P-t-9. Lane 1, 10 base pair DNA ladder. Lane 2, 3'-32 P-t-9 without any treatment. Lane 3, 3'-32 P-t-9 treated with CviQI. Lane 4, 3'-32 P-t-9 treated with BsrBI. (C.) Representative 15% denaturing PAGE gel analysis of restriction enzyme treatment of 5'-32 P-b-9. Lane 1, 10 base pair DNA ladder. Lane 2, 5'-32 P-b-9 without any treatment. Lane 3, 5'-32 P-b-9 treated with CviQI. Lane 4, 5'-32 P-b-9 treated with BsrBI. (D.) Representative 15% denaturing PAGE gel analysis of restriction enzyme treatment of 5'-32 P-t-9. Lane 1, 10 base pair DNA ladder. Lane 2, 5'-32 P-t-9 without any treatment. Lane 3, 5'-32 P-t-9 treated with BsrBI. Figure S6 . Thermal stability of 5'-32 P-t-9 analyzed using non-denaturing (20%) PAGE. Lane 1 and 2, aliquots at 0 and 60 min from single stranded 5'-32 P-10, respectively. Lane 3, hybridized 5'-32 P-t-9 without any treatment. Lanes 4 to 9, aliquots taken at 0, 5, 10, 15, 30 and 60 min from 5'-32 P-t-9 (2 nM) incubated with non-radiolabeled 10 (10 nM) in 1 × NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 50 mM KCl, 5 mM DTT, and ATP 1 mM) at 55 °C. Figure S12. Denaturing PAGE (20%) analysis of 8 h time course study of UvrABC incision on 3'-32 P-t-9. Lane 1, 10 base pair DNA ladder. Lane 2, 3'-32 P-t-9 incubated in 1 × NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 50 mM KCl, 5 mM DTT, and ATP 1 mM) without any treatment at 55 °C for 0 h. Lane 3, 3'-32 P-t-9 incubated in 1 × NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 50 mM KCl, 5 mM DTT, and ATP 1 mM) without any treatment at 55 °C for 8 h. Lane 4 to 10, aliquots (in triplicate) taken at 0, 1, 2, 3, 4, 6, and 8 h from incubation of 3'-32 P-t-9 incubated with UvrABC in 1 × NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 50 mM KCl, 5 mM DTT, and ATP 1 mM) at 55 °C. Lane 11, A+G sequencing reaction on 3'-32 P-t-9. Lane 12, T+C sequencing reaction on 3'-32 P-t-9. Figure S13 . Denaturing (20%) PAGE analysis of 1 h time course study of UvrABC incision on 5'-32 P-b-9. Lane 1, 5'-32 P-b-9 incubated in 1 × NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 50 mM KCl, 5 mM dTT, and ATP 1 mM) without any treatment at 55 °C for 0 min. Lane 2, 5'-32 P-b-9 incubated in 1 × NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 50 mM KCl, 5 mM dTT, and ATP 1 mM) without any treatment at 55 °C for 60 min. Lane 3 to 9, aliquots (in triplicate) taken at 0, 5, 10, 15, 30, and 60 min from incubation of 5'-32 P-b-9 incubated with UvrABC in 1 × NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 50 mM KCl, 5 mM dTT, and ATP 1 mM) at 55 °C. Lane 11, A+G sequencing reaction on 5'-32 P-b-9. Lane 12, T+C sequencing reaction on 5'-32 P-b-9. S25 Figure S14 . Time dependence of UvrABC incision of DOB ICL analogue 7 in 5'-32 P-b-9 compared to that in 5'-32 P-12. (Total amount of incision at all nucleotides in region between 32 Plabel and cross-link is plotted.) Figure S15 . Time dependence of UvrABC incision of DOB ICL analogue 7 in 3'-32 P-t-9 compared to that in 5'-32 P-12. (Total amount of incision at all nucleotides in region between 32 Plabel and cross-link is plotted.)
